Indication
Irritable Bowel Syndrome
2 registered trials testing Psilocybin for this indication, none currently recruiting.
Sponsors register this under 2 different names, all collected here: IBS - Irritable Bowel Syndrome · Irritable Bowel Syndrome
2
Registered trials
0
Recruiting
0
In Phase 3
Stay told
When a new trial opens
Trials
All 2 trials for Irritable Bowel Syndrome
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)NCT06206265 · TRYP Therapeutics | Active, not recruiting | Phase 2 | psilocybin | 1 |
| Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)NCT06760533 · NYU Langone Health | Not yet recruiting | Early Phase 1 | psilocybin | 1 |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.